ASTRAZENECA PLC DL-,25/ GB0009895292 /
22/07/2024 17:40:33 | Chg. +0.950 | Volume | Bid21:59:57 | Ask21:59:57 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
145.800EUR | +0.66% | 577 Turnover: 84,202.950 |
145.450Bid Size: 40 | 146.150Ask Size: 40 | 225.55 bill.EUR | - | - |
GlobeNewswire
26/06
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire
18/06
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire
18/06
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire
13/06
Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire
08/05
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
06/05
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
02/05
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
28/03
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...